Seagen Inc (SGEN)

전일 마감가:

$228.74

열려 있는:

$0

하루 거래량:

0

시가총액:

$43.15B

수익:

$2.30B

순이익/손실:

$-750.23M

주가수익비율:

0.00

EPS:

-4.01

순현금흐름:

$-701.21M

1주 성능:

-100.00%

1개월 성능:

-100.00%

6개월 성능:

-100.00%

1년 성능:

-100.00%

1일 변동 폭

$0.00

$0.00

52주 변동 폭

$0.00

$228.96

Seagen Inc Stock (SGEN) Company Profile

명칭

Seagen Inc

부문

Healthcare (1191)

산업

Biotechnology (688)

전화

425-527-4000

주소

21823 30th Drive SE, Bothell, WA

직원

1,100

트위터

@seattlegenetics

다음 수익 날짜

2023-11-01

최신 SEC 제출 서류

SGEN's Discussions on Twitter

Seagen Inc Stock (SGEN) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-02-16	업그레이드	Evercore ISI	In-line → Outperform
2023-02-16	업그레이드	Raymond James	Outperform → Strong Buy
2023-02-06	다운그레이드	SVB Securities	Outperform → Market Perform
2022-11-21	개시	Truist	Hold
2022-10-11	업그레이드	BMO Capital Markets	Market Perform → Outperform
2022-06-29	개시	Raymond James	Outperform
2022-06-24	개시	BMO Capital Markets	Market Perform
2022-02-10	재확인	BofA Securities	Buy
2022-02-10	재확인	H.C. Wainwright	Buy
2022-02-10	재확인	Morgan Stanley	Overweight
2022-02-10	재확인	Needham	Buy
2022-02-10	재확인	Piper Sandler	Neutral
2022-02-10	재확인	RBC Capital Mkts	Sector Perform
2022-02-10	재확인	SVB Leerink	Outperform
2022-02-10	재확인	Wolfe Research	Peer Perform
2022-01-31	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2021-11-09	개시	Wolfe Research	Peer Perform
2021-10-15	재개	BTIG Research	Neutral
2021-05-17	개시	Evercore ISI	In-line
2021-03-31	개시	Credit Suisse	Neutral
2021-02-01	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2021-01-15	업그레이드	BofA Securities	Neutral → Buy
2020-09-22	재확인	Stifel	Hold
2020-08-24	재개	Berenberg	Buy
2020-07-31	재확인	H.C. Wainwright	Buy
2020-07-24	다운그레이드	Piper Sandler	Overweight → Neutral
2020-05-26	개시	JMP Securities	Mkt Outperform
2020-05-01	업그레이드	Guggenheim	Neutral → Buy
2020-05-01	재확인	Needham	Buy
2020-02-18	다운그레이드	Barclays	Overweight → Equal Weight
2020-02-12	재확인	H.C. Wainwright	Buy
2020-02-11	재확인	Goldman	Buy
2020-01-28	개시	BMO Capital Markets	Outperform
2020-01-27	개시	BMO Capital Markets	Outperform
2020-01-02	다운그레이드	Guggenheim	Buy → Neutral
2019-12-10	개시	Morgan Stanley	Equal-Weight
2019-12-03	재개	BofA/Merrill	Neutral
2019-10-22	재확인	BofA/Merrill	Underperform
2019-10-22	재확인	H.C. Wainwright	Buy
2019-09-27	업그레이드	Goldman	Neutral → Buy
2019-08-26	개시	BTIG Research	Neutral
2019-07-18	개시	Deutsche Bank	Hold

모두보기

Seagen Inc 주식(SGEN)의 최신 뉴스

Pfizer's 2030 Vision Bolstered By Seagen Deal, Analyst Cuts Price Target Amid Conservative 2024 Forecast

Benzinga

Pfizer (PFE) Stock Sinks on Weak 2024 View as COVID Sales Fall

Zacks Investment Research

Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?

The Motley Fool

Pfizer's Dividend Yield Is 5.7%, Plus Humana And Shake Shack On CNBC's 'Final Trades'

Benzinga

Bristol Myers Squibb's Mega $8.4B Oncology Bet - Secures Exclusive License With SystImmune

Benzinga

Why Is Seattle Genetics (SGEN) Down 0.7% Since Last Earnings Report?

Zacks Investment Research

Seagen Inc (SGEN) 재무 분석

Seagen Inc (SGEN) 매출 2024

Seagen Inc (SGEN) 순이익 2024

Seagen Inc (SGEN) 현금흐름 2024

Seagen Inc (SGEN) 주당 순이익 2024